ImportRefusal LogoImportRefusal

NeoPharm Co., Ltd.

Low Risk

FEI: 3007421949 • Yuseong-gu, Daejeon • SOUTH KOREA

FEI

FEI Number

3007421949

📍

Location

Yuseong-gu, Daejeon

🇰🇷
🏢

Address

309-8 Techno 2-ro, , Yuseong-gu, Daejeon, South Korea

Low Risk

FDA Import Risk Assessment

23.3
LowModerateHighCritical

This firm has a minimal history of FDA import refusals with low-severity violations.

Statistics

2
Total Refusals
2
Unique Violations
2/21/2006
Latest Refusal
7/20/2005
Earliest Refusal

Score Breakdown

Violation Severity
40.0×40%
Refusal Volume
17.7×30%
Recency
0.0×20%
Frequency
20.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

29401×

COSM MISB

The cosmetic's labeling appears to be false or misleading within the meaning of Section 201(n).

4711×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

Refusal History

DateProductViolationsDivision
2/21/2006
53LC06MOISTURIZING (SKIN CARE PREPARATIONS)
2940COSM MISB
Los Angeles District Office (LOS-DO)
7/20/2005
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
471CSTIC LBLG
Los Angeles District Office (LOS-DO)

Frequently Asked Questions

What is NeoPharm Co., Ltd.'s FDA import refusal history?

NeoPharm Co., Ltd. (FEI: 3007421949) has 2 FDA import refusal record(s) in our database, spanning from 7/20/2005 to 2/21/2006.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. NeoPharm Co., Ltd.'s FEI number is 3007421949.

What types of violations has NeoPharm Co., Ltd. received?

NeoPharm Co., Ltd. has been cited for 2 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about NeoPharm Co., Ltd. come from?

All FDA import refusal data for NeoPharm Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.